Molecules containing more than 50 amino acids are called proteins. Proteins are products produced from organisms and living systems by biological methods as the active ingredient of biotechnological drugs, and it is possible to produce some proteins synthetically. Protein-containing drugs can be counted as some blood products and various immunological products. Biosimilars, on the other hand, are biological drugs similar to the original products produced after the patent expiration of the original biotechnological products.

CT Pharma Research provides consultancy services for the development of products in this category in accordance with current regulations.